DHR
Price
$211.59
Change
-$3.40 (-1.58%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
153.94B
15 days until earnings call
WAT
Price
$327.66
Change
-$0.73 (-0.22%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
19.55B
29 days until earnings call
Interact to see
Advertisement

DHR vs WAT

Header iconDHR vs WAT Comparison
Open Charts DHR vs WATBanner chart's image
Danaher
Price$211.59
Change-$3.40 (-1.58%)
Volume$17.99K
Capitalization153.94B
Waters
Price$327.66
Change-$0.73 (-0.22%)
Volume$1.4K
Capitalization19.55B
DHR vs WAT Comparison Chart in %
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. WAT commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and WAT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (DHR: $214.99 vs. WAT: $328.39)
Brand notoriety: DHR and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 143% vs. WAT: 99%
Market capitalization -- DHR: $153.94B vs. WAT: $19.55B
DHR [@Medical Specialties] is valued at $153.94B. WAT’s [@Medical Specialties] market capitalization is $19.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 1 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, both DHR and WAT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 4 TA indicator(s) are bullish while WAT’s TA Score has 6 bullish TA indicator(s).

  • DHR’s TA Score: 4 bullish, 6 bearish.
  • WAT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than DHR.

Price Growth

DHR (@Medical Specialties) experienced а +16.31% price change this week, while WAT (@Medical Specialties) price change was +12.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.58%. For the same industry, the average monthly price growth was +7.27%, and the average quarterly price growth was +35.87%.

Reported Earning Dates

DHR is expected to report earnings on Oct 21, 2025.

WAT is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+3.58% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($154B) has a higher market cap than WAT($19.5B). DHR has higher P/E ratio than WAT: DHR (44.66) vs WAT (29.03). DHR YTD gains are higher at: -5.885 vs. WAT (-11.480). DHR has higher annual earnings (EBITDA): 6.76B vs. WAT (1.06B). WAT has less debt than DHR: WAT (1.54B) vs DHR (17.4B). DHR has higher revenues than WAT: DHR (24B) vs WAT (3.05B).
DHRWATDHR / WAT
Capitalization154B19.5B790%
EBITDA6.76B1.06B639%
Gain YTD-5.885-11.48051%
P/E Ratio44.6629.03154%
Revenue24B3.05B788%
Total CashN/A367M-
Total Debt17.4B1.54B1,131%
FUNDAMENTALS RATINGS
DHR vs WAT: Fundamental Ratings
DHR
WAT
OUTLOOK RATING
1..100
1028
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
7158
SMR RATING
1..100
7925
PRICE GROWTH RATING
1..100
5254
P/E GROWTH RATING
1..100
5578
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (26) in the Medical Specialties industry is somewhat better than the same rating for WAT (88). This means that DHR’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (58) in the Medical Specialties industry is in the same range as DHR (71). This means that WAT’s stock grew similarly to DHR’s over the last 12 months.

WAT's SMR Rating (25) in the Medical Specialties industry is somewhat better than the same rating for DHR (79). This means that WAT’s stock grew somewhat faster than DHR’s over the last 12 months.

DHR's Price Growth Rating (52) in the Medical Specialties industry is in the same range as WAT (54). This means that DHR’s stock grew similarly to WAT’s over the last 12 months.

DHR's P/E Growth Rating (55) in the Medical Specialties industry is in the same range as WAT (78). This means that DHR’s stock grew similarly to WAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRWAT
RSI
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
67%
MACD
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
64%
Advances
ODDS (%)
Bullish Trend 6 days ago
53%
Bullish Trend 4 days ago
66%
Declines
ODDS (%)
Bearish Trend 12 days ago
60%
Bearish Trend 12 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
55%
Aroon
ODDS (%)
Bearish Trend 4 days ago
49%
Bullish Trend 4 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IGLD23.920.14
+0.61%
FT Vest Gold Strategy Trgt Inc ETF
XYZG23.850.14
+0.59%
Leverage Shares 2X Long XYZ Daily ETF
MAPP26.410.08
+0.32%
Harbor Multi-Asset Explorer ETF
TILT243.880.43
+0.18%
FlexShares Mstar US Mkt Factors Tilt ETF
EMCB66.93-0.11
-0.16%
WisdomTree Emerging Markets Corp Bd ETF